跳至主要内容
临床试验/CTRI/2023/01/049235
CTRI/2023/01/049235尚未招募2 期

â??A randomized open labelled controlled clinical study to evaluate the efficacy of Bilva Taila Karnapoorana with Brahmi Ghrita orally in the management of Karnanada and Karnakshweda with special reference to Tinnitusâ??

Dr Mohammed Irfan0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Subjects within the age of 21 to 60 years irrespective of gender, occupation, religion, socio- economic status and duration of illness. 1. Subjects having mild to moderate hearing loss. 2. Subjects who fulfill the diagnostic Criteria. 3. Subjects willing to participate in the study with written informed consent, which is conveyed in the language which the subject can understand. 4. Subjects with tinnitus who were not undergoing treatment for tinnitus in the last six months.

排除标准

  • 1. Subjects having perforated tympanic membrane.
  • 2. Subjects having any uncontrolled systemic illness which can interfere with the course of disease and treatment.
  • 3. Subjects having congenital deformity of ear.
  • 4. Subjects diagnosed with other diseases like tumors of ear, Aneurysms of carotid artery, Meningitis, Meniereâ??s disease, Acute suppurative otitis media and Chronic suppurative otitis media.
  • 5. Subjects with hearing aids, hearing asymmetry or retro cochlear pathology, metabolic or psychiatric diseases.
  • 6. Subjectsâ?? incapable of filling/answering Tinnitus Handicap Inventory, Clinical Global Impression of Improvement (CGI-I) scale.
  • 7. Pregnant and lactating women.

研究者

发起方
Dr Mohammed Irfan

相似试验